CAVA
Analyst target raises behind the outperformance
- CAVA +4.50% on the last session vs SPY −0.25%: +4.8 pts of stock-specific move.
- 1 analyst action in the past 10 days (1 positive, 0 negative); latest: Melius Research upgraded to Buy, target $95.00.
- Market backdrop (Today): Core PPI m/m 1.3% vs 0.3% expected (hotter); Core Retail Sales m/m 0.9% vs 0.6% expected (stronger); S&P futures -0.08%, 10-year yield -3bp in the 30 minutes after.
Insiders
| Trade date | Insider | Role | Side | Type | Shares | Avg price | Value | Filed |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Joseph John Kadow | CLO & Secretary | Buy | open-market buy | 1,000 | $49.96 | $50K | Sep 16 |
| Aug 31, 2026 | Douglas W. Thompson | Chief Operations Officer | Buy | open-market buy | 6,500 | $66.52 | $432.4K | Sep 2 |
| Jun 18, 2026 | Karen Kochevar | Director | Sell | unplanned | 10,000 | $90.00 | $900K | Jun 23 |
| Jun 17, 2026 | Kelly Costanza | Chief People Officer | Sell | unplanned | 15,360 | $89.89 | $1.4M | Jun 17 |
| Jun 15, 2026 | Participations S.a R.l. Artal | Director | Sell | unplanned | 3,000,000 | $90.30 | $270.9M | Jun 17 |
| Jun 15, 2026 | Theodoros Xenohristos | Director | Sell | unplanned | 3,252 | $89.43 | $290.8K | Jun 17 |
| Jun 15, 2026 | Adam David Phillips | CAO | Sell | unplanned | 757 | $89.43 | $67.7K | Jun 17 |
| Jun 15, 2026 | Tricia K. Tolivar | CFO | Sell | unplanned | 4,969 | $89.43 | $444.4K | Jun 17 |
| Jun 15, 2026 | Brett Schulman | CEO | Sell | unplanned | 33,174 | $89.43 | $3M | Jun 17 |
| Jun 12, 2026 | Adam David Phillips | CAO | Sell | unplanned | 4,664 | $90.71 | $423.1K | Jun 15 |
| Jun 3, 2026 | Joseph John Kadow | CLO & Secretary | Buy | open-market buy | 1,000 | $70.00 | $70K | Jun 5 |
| May 29, 2026 | Joseph John Kadow | CLO & Secretary | Buy | open-market buy | 1,000 | $79.00 | $79K | Jun 2 |
| May 29, 2026 | Douglas W. Thompson | Chief Operations Officer | Buy | open-market buy | 2,500 | $77.90 | $194.8K | Jun 2 |
| May 26, 2026 | Douglas W. Thompson | Chief Operations Officer | Buy | open-market buy | 4,000 | $79.45 | $317.8K | May 28 |
| May 21, 2026 | Kelly Costanza | Chief People Officer | Sell | unplanned | 10,010 | $79.87 | $799.5K | May 22 |
| May 21, 2026 | Adam David Phillips | CAO | Sell | unplanned | 5,181 | $77.14 | $399.7K | May 22 |
| May 11, 2026 | Theodoros Xenohristos | Director | Sell | unplanned | 9,044 | $79.75 | $721.3K | May 12 |
| Mar 5, 2026 | Kenneth Robert Bertram | CLO & Secretary | Sell | unplanned | 15,000 | $80.33 | $1.2M | Mar 6 |
| Feb 26, 2026 | Kelly Costanza | Chief People Officer | Sell | unplanned | 31,803 | $84.45 | $2.7M | Mar 2 |
| Feb 26, 2026 | Adam David Phillips | CAO | Sell | unplanned | 2,000 | $85.54 | $171.1K | Mar 2 |
| Jan 27, 2026 | Kelly Costanza | Chief People Officer | Sell | unplanned | 1,707 | $62.14 | $106.1K | Jan 29 |
| Jan 27, 2026 | Kenneth Robert Bertram | CLO & Secretary | Sell | unplanned | 994 | $62.14 | $61.8K | Jan 29 |
| Jan 27, 2026 | Adam David Phillips | CAO | Sell | unplanned | 774 | $62.14 | $48.1K | Jan 29 |
| Jan 27, 2026 | Theodoros Xenohristos | Director | Sell | unplanned | 1,039 | $62.14 | $64.6K | Jan 29 |
| Jan 27, 2026 | Brett Schulman | CEO | Sell | unplanned | 4,542 | $62.14 | $282.3K | Jan 29 |
| Jan 27, 2026 | Tricia K. Tolivar | CFO | Sell | unplanned | 2,404 | $62.14 | $149.4K | Jan 29 |
| Jan 21, 2026 | Kenneth Robert Bertram | CLO & Secretary | Sell | unplanned | 1,074 | $67.41 | $72.4K | Jan 23 |
| Jan 21, 2026 | Kelly Costanza | Chief People Officer | Sell | unplanned | 1,702 | $67.41 | $114.7K | Jan 23 |
| Jan 21, 2026 | Tricia K. Tolivar | CFO | Sell | unplanned | 2,204 | $67.41 | $148.6K | Jan 23 |
| Jan 21, 2026 | Brett Schulman | CEO | Sell | unplanned | 21,650 | $67.41 | $1.5M | Jan 23 |
| Jan 21, 2026 | Theodoros Xenohristos | Director | Sell | unplanned | 965 | $67.41 | $65.1K | Jan 23 |
| Nov 26, 2025 | Kenneth Robert Bertram | CLO & Secretary | Sell | unplanned | 3,788 | $50.70 | $192.1K | Nov 28 |
| Nov 12, 2025 | Brett Schulman | CEO | Buy | open-market buy | 150 | $48.98 | $7.3K | Nov 12 |
| Sep 29, 2025 | Kenneth Robert Bertram | CLO & Secretary | Sell | unplanned | 3,771 | $58.86 | $222K | Oct 1 |
Officers, directors and 10% owners file SEC Form 4 within two business days. Unplanned: the insider chose to trade now, the trades worth attention; their dollars make the net above. 10b5-1 plan: scheduled in advance, kept for the record. Tax: shares withheld on vesting stock, not a market trade. Awards, option exercises and gifts are left out. Source: SEC EDGAR, collected daily for the stocks discussed on Reddit.
Congress
Members of Congress report trades within 45 days of the trade date, so these are never real-time. Amounts are disclosed as ranges; the net uses each range's midpoint (≈). Source: House and Senate periodic transaction reports via CongressInvests, refreshed daily.
Funds
| Investor | Shares | Value | Of its portfolio | Vs quarter before | As of |
|---|---|---|---|---|---|
| Bridgewater (Ray Dalio's firm) | 6,226 | $488.6K | 0.00% | -1% | Q2 2026 |
Well-known investors we follow (Buffett, Ackman, Icahn, Druckenmiller, Tepper, Soros and others). 13F: managers report their US stock holdings up to 45 days after each quarter; the change from the quarter before is dated by the filing, the trades happened some time in the quarter, and the value is at the quarter-end price (≈). New and closed positions, and adds or cuts of 20% or more, of positions at least 0.2% of the portfolio. ARK: Cathie Wood's ETFs publish their holdings every morning; the change beyond the fund's own inflows and outflows, dated by the session it traded. 5%+ stake: Schedule 13D (with intent to influence) or 13G (passive), filed within days. Source: SEC EDGAR, ark-funds.com, refreshed daily. Who holds it: each investor's latest 13F portfolio (positions at the quarter's end; one sold since would not show until the next filing), and ARK's ETFs as of their latest daily file. The funds we follow and their portfolios · All recent insider, congressional and fund moves